USPTO serial 87225228
PACEMETIC
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- WATTS-FITZGERALD, CAITLIN C
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PACEMETIC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
64293 Darmstadt, DE
64293 Darmstadt, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William C. Wright
WILLIAM C. WRIGHT EPSTEIN DRANGEL LLP60 EAST 42ND STREET, SUITE 2520NEW YORK, NY 10165UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science; Chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals | ACTIVE | — |
| 005 | Pharmaceutical for the treatment of cardiovascular diseases and disorders, diabetic diseases and disorders, endocrinological diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, growth hormones diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, musculo-skeletal diseases and disorders, neurological diseases and disorders, oncological diseases and disorders, pulmonary diseases and disorders, reproductive health diseases and disorders, rheumatological diseases and disorders, viral infections; 3-d printed pharmaceuticals, namely, personalized combinations and dosages of active pharmaceutical ingredients in the form of 3d-printed pharmaceutical tablets for the treatment of cardiovascular diseases and disorders, diabetic diseases and disorders, endocrinological diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, growth hormones diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, musculo-skeletal diseases and disorders, neurological diseases and disorders, oncological diseases and disorders, pulmonary diseases and disorders, reproductive health diseases and disorders, rheumatological diseases and disorders, viral infections | ACTIVE | — |
| 007 | Pharmaceutical processing machine in the nature of a pharmaceutical tablet press; machines for the manufacture of pharmaceutical tablets, namely, pharmaceutical tablet printing machines; Scientific apparatus and instruments, namely, 3D printers for the lab scale manufacture of pharmaceutical tablets | ACTIVE | — |
| 044 | Dispensing of pharmaceuticals; medical pharmaceutical consultancy services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MERCK KGAA
- Other trademarks owned by MERCK KGAA
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 007
- Other trademarks in Class 044
- Similar marks named PACEMETIC
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 18, 2018 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 18, 2018 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 14, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 19, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 19, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 30, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 11, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 11, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 11, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 11, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 11, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 30, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 30, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 30, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 29, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 28, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 28, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 6, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 6, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 6, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 5, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 7, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 7, 2016 | NWAP | NEW APPLICATION ENTERED | — |